Attached is a "high volume" counterparty list for two categories.
With  respect to the first category, Carol is handling BPAmoco and I am speaking  with Cargill.
Should we address Neumin?
And should we actively try to  replace existing ECT masters with ISDA's?
Sara

Counterparties with high volume of trades for 1999